WEST PHARMACEUTICAL SERVICES INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
West Pharmaceutical Services Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2010 to Q3 2024.
  • West Pharmaceutical Services Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 72.8M shares, a 2.02% decline year-over-year.
  • West Pharmaceutical Services Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 74.3M shares, a 0.13% decline from 2022.
  • West Pharmaceutical Services Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 74.4M shares, unchanged from 2021.
  • West Pharmaceutical Services Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 74.4M shares, a 0.68% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 72.8M -1.5M -2.02% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-24
Q2 2024 73M -1.3M -1.75% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 73.5M -1M -1.34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 74.3M -100K -0.13% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 74.3M -100K -0.13% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-24
Q2 2023 74.3M -100K -0.13% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 74.5M +100K +0.13% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 74.4M 0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 74.4M +300K +0.41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 74.4M +400K +0.54% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 74.4M +500K +0.68% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 74.4M +500K +0.68% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 74.1M +200K +0.27% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 74M +200K +0.27% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 73.9M 0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 73.9M -100K -0.14% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 73.9M -100K -0.14% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 73.8M +100K +0.14% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 73.9M -200K -0.27% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 74M +100K +0.14% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 74M +100K +0.14% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 73.7M +100K +0.14% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-24
Q1 2019 74.1M +200K +0.27% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-24
Q4 2018 73.9M 0 0% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 73.9M -300K -0.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-29
Q2 2018 73.6M -300K -0.41% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 73.9M +600K +0.82% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 73.9M +600K +0.82% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 74.2M +900K +1.23% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 73.9M +600K +0.82% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 73.3M +800K +1.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 73.3M +1.3M +1.81% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 73.3M +1.1M +1.52% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 73.3M +1.3M +1.81% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 72.5M +800K +1.12% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 72M +1.1M +1.55% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 72.2M +1.2M +1.69% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-31
Q2 2015 72M +1.2M +1.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 71.7M +1.1M +1.56% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 70.9M +1.3M +1.87% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 71M +1.2M +1.72% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 70.8M +1.3M +1.87% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-03
Q1 2014 70.6M +1.6M +2.32% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 69.6M +1.5M +2.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 69.8M +1.5M +2.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 69.5M +35.5M +104% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 69M +35.1M +104% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 68.1M +800K +1.19% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 68.3M +34.5M +102% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 34M +400K +1.19% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 33.9M +500K +1.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 67.3M +34M +102% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 33.8M +400K +1.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 33.6M +300K +0.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 33.4M +300K +0.91% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 33.3M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 33.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 33.3M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-08
Q1 2010 33.1M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.